
Trajone Taz 250mg/31.5mg Injection
Marketer
Swastik Life Sciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.5mg)
Overview Trajone Taz 250mg/31.5mg Injection
Tazone 250mg/31.5mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administer this medication strictly as directed by your physician. Complete the prescribed course, regardless of symptom improvement; premature cessation may compromise its efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects or allergic reactions (rash, itching, swelling, respiratory distress) immediately. Inform your doctor of all current medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally non-impairing, refrain from driving if experiencing drowsiness or dizziness. Rest, nutrition, and hydration are crucial for optimal recovery. Your doctor may order tests to monitor the medication's effectiveness.
Uses of Trajone Taz 250mg/31.5mg Injection
Infections caused by bacteria
Major Benefits of Trajone Taz 250mg/31.5mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Trajone Taz 250mg/31.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Trajone Taz 250mg/31.5mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Trajone Taz 250mg/31.5mg Injection works:
Ceftriaxone/Tazobactam (Trajone Taz 250mg/31.5mg Injection) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Trajone Taz 250mg/31.5mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
Administration of Trajone Taz 250mg/31.5mg Injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Trajone Taz 250mg/31.5mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Trajone Taz 250mg/31.5mg Injection might induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Trajone Taz 250mg/31.5mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Trajone Taz 250mg/31.5mg Injection cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Dosage alteration for Trajone Taz 250mg/31.5mg Injection is unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Trajone Taz 250mg/31.5mg Injection :
Should you forget a scheduled Trajone Taz 250mg/31.5mg Injection, seek immediate medical advice.
Facts to Know About Trajone Taz 250mg/31.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
